Regulatory
The pharma market is built on a strong regulatory foundation. Here you can learn how both established guidance and recent changes impact manufacturers and developers.
A summary of the regulatory landscape for established modalities such as small molecules and biologics, and dive deeper into the evolving regulations for the newer modalities, such as cell and gene therapies. We list some critical U.S. holds that impacted the development of subsequent drugs and discuss the rising influence of regulatory agencies around the world.
